Amplify Weight Loss Drug & Treatment ETF (THNR)

NYSE
Currency in USD
22.79
-0.37(-1.60%)
Closed·
After Hours
22.790.00(0.00%)
·
Day's Range
22.7922.79
52 wk Range
18.5628.19

Key Statistics

Morning Star Rating
-
Risk Rating
-
Bid / Ask
-
Prev. Close
22.79
Price Open
22.79
Volume
249
Average Vol. (3m)
2,265
1-Year Change
-14.19%
Day’s Range
22.79-22.79
52-Week Range
18.56-28.19
Market Cap
66.03B
Expense Ratio
0.59%
How do you feel today about THNR?
Vote to see community's results!
or

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Performance

Name
YTD
3M
1Y
3Y
5Y
10Y
Growth of 1000983945894---
Fund Return-1.66%-5.54%-10.64%---
Rank in Category2818141---
Percentile Rank241781---

Novo Nordisk AS ADR

-14.76%--5,656
LLY14.01%771.75-3.45%536

Innovent Biologics Inc

-7.62%--23,000

Hims & Hers Health Inc Ordinary Shares - Class A

-6.48%--3,519
45195.24%6,800.0-0.72%3,100
TEVA4.96%16.04-2.31%8,694
WST4.63%221.05-1.53%640

AstraZeneca PLC ADR

-4.53%--1,874
ROG4.51%255.40+0.16%418
PFE4.47%24.61-2.92%5,592

Amplify Weight Loss Drug & Treatment ETF Company Profile

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF is an exchange traded fund launched and managed by Amplify Investments LLC. The fund is co-managed by Penserra Capital Management LLC. It invests in public equity markets of global region. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences, pharmaceuticals, GLP-1 agonist drugs, drug manufacturers and enablers engaged in outsourced development and manufacturing of GLP-1 agonist drugs sectors. It invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the VettaFi Weight Loss Drug & Treatment Index, by using full replication technique. Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF was formed on May 21, 2024 and is domiciled in the United States.

Industry
-
Sector
-
0
Equity Type
ETF

FAQ

How is the performance of THNR?

As of 16 Jul 2025, THNR is trading at a price of 22.79, with a previous close of 22.79. The stock has fluctuated within a day range of 22.79 to 22.79, while its 52-week range spans from 18.56 to 28.19.

What is the current price of THNR?

The THNR stock price today is 22.79.

Does THNR Pay Dividends? What’s The Current Dividend Yield?

The Amplify Weight Loss Drug & Treatment dividend yield is 0.96%.

What is the P/E ratio of THNR?

The P/E ratio for THNR is 15.59.

From a Technical Analysis Perspective, Is THNR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

What is the THNR market cap?

The market cap for THNR is 2.96M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.